Rectal Indomethacin

DRUG5 trials

Sponsors

Johns Hopkins University, First People's Hospital of Hangzhou, David Vitale MD, Moti Lal Nehru Medical College

Conditions

Pancreatitis, Acute NecrotizingPost-ERCP Acute PancreatitisPost-ERCP Pancreatitis

Phase 3

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

RecruitingNCT05252754

Johns Hopkins UniversityPost-ERCP Acute Pancreatitis

Start: 2023-01-18End: 2026-12-31Target: 4874Updated: 2025-12-09

Phase 4

Rectal Indomethacin vs Intravenous Ketorolac

CompletedNCT05664074

David Vitale MDPost-ERCP Acute Pancreatitis

Start: 2022-11-07End: 2025-02-05Updated: 2026-03-12

Unknown Phase

Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

CompletedNCT02116309

Johns Hopkins UniversityPost-ERCP Acute Pancreatitis

Start: 2014-08-31End: 2016-12-02Updated: 2017-11-01

The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis

CompletedNCT03643900

First People's Hospital of HangzhouPancreatitis, Acute Necrotizing, Post-ERCP Pancreatitis

Start: 2018-08-08End: 2021-08-18Updated: 2021-08-30

Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis

Moti Lal Nehru Medical CollegePost-ERCP Acute Pancreatitis

Start: 2023-05-10End: 2024-05-01Target: 384Updated: 2023-06-28

Related Papers

Rectal INdomethacin, oral TacROlimus, or their combination for the prevention of post-ERCP pancreatitis (INTRO Trial): Protocol for a randomized, controlled, double-blinded trial.

2022-07-195 citations

A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients

The American Journal of Gastroenterology2019-01-2440 citations